The medication-safety management system
Governance, safeguards, reconciliation, event learning, competency, recalls, corrective action and improvement within the approved scope.
At a glance
Eligibility review is free. You pay nothing until eligibility is confirmed and an agreement is signed.
For hospitals, health systems and pharmacies — independent review of how your medication-safety system governs, prevents, detects and learns from medication risk, not just how it is written down.
501(c)(3) nonprofit · Standards published · Independent decision · Publicly verifiable

MSS is designed for hospitals, health systems, pharmacies and medication-management organizations accountable for defined medication-use systems.
Governance, high-risk safeguards, technology, learning and improvement.
How an organization defines, assesses and maintains workforce competence.
Clinical education governance, delivery and quality assurance.
Credential governance, psychometrics, eligibility and certification decisions.
Scope is explicit. Accreditation applies only to the defined medication-use safety system, care setting, service line or operating unit approved in the CHSPS record.
Governance, safeguards, reconciliation, event learning, competency, recalls, corrective action and improvement within the approved scope.
Prescribing, verification, preparation, storage, administration, monitoring, learning, technology and resilience controls applicable to the defined system.
Individual clinicians, pharmacy licenses, medication products, unrelated services and organization-wide hospital or regulatory accreditation are not implied.
Edition 2026.1. Continuous eligibility intake. Accreditation term: 3 years.
MSS follows the medication-use system from governance and risk assessment through frontline controls, learning, workforce competence and performance.
Named accountability, priorities, committee authority and executive oversight.
Proactive assessment of medication-use hazards and control weakness.
Medication reconciliation and high-risk transitions of care.
Enhanced safeguards, standardization and monitoring.
Order design, decision support, alert governance and override review.
Clinical and dispensing verification controls appropriate to risk.
Labeling, storage, preparation, distribution and environmental controls.
Patient, drug, dose, route and timing safeguards including technology.
Adverse-event detection, laboratory monitoring and follow-up.
Error and near-miss reporting, analysis, CAPA and learning dissemination.
BCMA, smart pumps, automation, interfaces and downtime safeguards.
Shortages, substitutions, recalls and supply-chain response.
Medication-safety risks that intersect with controlled-substance oversight.
Role-specific medication-safety competence and high-risk skills.
Patient/caregiver education, reporting and high-risk communication.
Validated safety measures, trend review and improvement.
Technical review combines documents with source evidence, interviews, demonstrations and end-to-end tracers.
The free review confirms MSS fit and proposed scope before CHSPS starts a paid engagement.
No fee and no commitment.
Application fee after scope confirmation and signed agreement.
Review balance when evidence is submitted.
MSS uses the same independent seven-stage accreditation architecture used across CHSPS pathways.
Confirm MSS fit and proposed medication-safety scope.
Receive written scope confirmation and execute the applicant agreement.
Submit governance, high-alert, CDS, incident, CAPA, competency and performance evidence.
Conflict-screened reviewers evaluate CORE-100 + MSS-310 evidence and tracers.
Resolve findings and provide corrective evidence where required.
A separate decision body determines accreditation status.
Approved scope, dates and status become publicly verifiable.
Independent assurance focused on the medication-safety controls that matter when patient safety, quality or governance is challenged.
External evaluation of the defined medication-safety management system beyond internal quality assurance.
Review spanning prescribing, verification, preparation, administration, monitoring and learning.
Evidence that events lead to analysis, corrective action, effectiveness review and organizational learning.
A CHSPS record identifying the exact accredited medication-safety scope and current status.
Use the free eligibility review to resolve MSS scope questions before any paid engagement begins.
MSS remains a continuing relationship throughout the three-year term. ACC-109 governs the common maintenance cycle.
Annual reporting may address:
Examples include:
Renewal revalidates:
Technical transparency remains available without forcing every accreditation buyer through the measure system before understanding the engagement.
CHSPS reference criteria are controlled technical references, not observed industry averages and not automatic accreditation thresholds unless a normative standard expressly incorporates them.
Required medication reconciliation completed within the defined transition window.
Sampled high-alert medication encounters meeting defined safeguards.
Serious preventable medication-harm events using a controlled definition.
Corrective actions closed on time with effectiveness review.
Critical medication recalls completed within defined response targets.
Medication-safety competencies current for defined high-risk roles.
The controlled standard remains authoritative for clause-level requirements, evidence expectations and review interpretation.
CHSPS education is optional, separately operated and has no influence on accreditation findings or decisions.
CHSPS webinars on the standards, the review and readiness planning. Registration is free.
See webinars$5,500 for the initial specialty review: the $1,250 application fee when you sign the applicant agreement, then the $4,250 review balance when you submit evidence. After that, $1,500 a year and a $3,500 renewal review every 3 years. A concurrent additional specialty scope in the same organization is $2,750. The eligibility review is free.
The free eligibility review targets a written outcome within 10 business days after a complete inquiry. CHSPS does not publish a single planning target for this pathway; the review timeline is stated in writing at scope confirmation, before you pay anything.
Nothing to upload. Step 1 asks only for your name, email and organization; the rest of the form covers scope, operating status and readiness, in about 5 minutes. Formal evidence comes after the agreement is signed: governance, high-alert medication, clinical decision support, incident, corrective-action, competency and performance evidence.
Yes. CHSPS is a United States–based 501(c)(3) nonprofit; organizations in any country may apply.
Every eligibility review ends in a written outcome: Eligible, Potentially Eligible — Additional Information Required, or Not Eligible, with the specific thresholds not yet met. There is no charge for the review, and if a different CHSPS pathway fits better, the review says so.
Confirm whether MSS is the right specialty pathway and what medication-safety scope would be reviewed before any paid application step.
CHSPS is an independent accreditor. CHSPS is a United States–based 501(c)(3) nonprofit; organizations in any country may apply.